Table 3:

Adverse outcomes after planned CDMR and planned vaginal delivery among women with low-risk singleton pregnancies resulting in a live or intrapartum stillbirth delivery in Ontario, Canada, between 2012 and 2018 (n = 422 210)

AOI componentNo. (%) of planned CDMR*
n = 1827
No. (%) of planned vaginal delivery*
n = 420 383
Planned CDMR v. planned vaginal delivery*
Crude RR* (95% CI)Adjusted RR (95% CI)
Maternal component
 Maternal death0 (0.0)14 (0.0)
 Uterine rupture0 (0.0)100 (0.0)
 Maternal intensive care unit admissionS446 (0.1)SS
 Unanticipated operative procedure21 (1.2)2212 (0.5)2.18 (1.42 to 3.35)2.00 (1.30 to 3.08)
 Blood transfusion19 (1.0)3057 (0.7)1.43 (0.91 to 2.24)1.46 (0.93 to 2.30)
 3rd or 4th degree perineal tear0 (0.0)13 686 (3.3)
Any maternal components37 (2.0)18 336 (4.4)0.46 (0.34 to 0.64)0.41 (0.30 to 0.57)
Fetal or neonatal components
 Intrapartum or in-hospital newborn death with birth weight ≥ 2500 g, with no congenital anomalies0 (0.0)301 (0.1)
 Birth trauma, ≥ 2000 g0 (0.0)2439 (0.6)
 NICU admission > 2 d or transfer within 24 h of birth to a facility with a NICU for an infant ≥ 2500 g30 (1.6)12 479 (3.0)0.55 (0.39 to 0.79)0.52 (0.36 to 0.74)
 5-minute Apgar score < 7S5353 (1.3)SS
Any neonatal component34 (1.9)17 899 (4.3)0.44 (0.31 to 0.61)0.42 (0.30 to 0.58)
Any AOI component70 (3.8)34 999 (8.3)0.46 (0.37 to 0.58)0.42 (0.33 to 0.54)
  • Note: AOI = Adverse Outcome Index, BMI = body mass index, CDMR = cesarean delivery on maternal request, CI = confidence interval, NICU = neonatal intensive care unit, RR = relative risk.

  • * Numbers are suppressed (S) for small cell sizes (n < 6).

  • Adjusted for gestational age, maternal age, pre-pregnancy BMI, neighbourhood education quintile, maternal race, parity, conception type, anxiety, maternal substance use during pregnancy (includes self-reported alcohol, smoking and drug use during pregnancy), antenatal health care provider and maternal hospital level of care. C-statistic: 0.643.